APA (7th ed.) Citation

Klco, J. M., Spencer, D. H., Lamprecht, T. L., Sarkaria, S. M., Wylie, T., Magrini, V., . . . Ley, T. J. (2013). Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood, 121(9), 1633. https://doi.org/10.1182/blood-2012-09-459313

Chicago Style (17th ed.) Citation

Klco, Jeffery M., et al. "Genomic Impact of Transient Low-dose Decitabine Treatment on Primary AML Cells." Blood 121, no. 9 (2013): 1633. https://doi.org/10.1182/blood-2012-09-459313.

MLA (9th ed.) Citation

Klco, Jeffery M., et al. "Genomic Impact of Transient Low-dose Decitabine Treatment on Primary AML Cells." Blood, vol. 121, no. 9, 2013, p. 1633, https://doi.org/10.1182/blood-2012-09-459313.